Target intelligence / Profile preview

Tumor cell membrane disruption

Molecular classification
Other
01

Overview

"Tumor cell membrane disruption" refers to the breakdown of the plasma membrane integrity in cancer cells, leading to cell death. This effect can be caused by various therapeutic agents, particularly anticancer peptides (AMPs, ACPs), that exploit differences in cancer cell membrane composition—such as higher negative charge, lower cholesterol content, and altered microvilli structures—to selectively interact with and destabilize tumor but not normal cell membranes. Disruption occurs via pore formation, membrane destabilization, or lytic mechanisms, ultimately resulting in necrosis or apoptosis depending on the agent and mode of action. While it is a valuable anticancer strategy, it is not a canonical molecular target, but a therapeutic approach or effect.

02

Mechanism of action

Induction of plasma membrane permeabilization via direct interaction with the lipid bilayer (“barrel-stave”, “carpet”, and pore-forming models). Ion channel formation (permitting leakage of ions). Triggering necrotic or apoptotic cell death through loss of membrane integrity.

03

Biological functions

Cell deathCell membrane disruptionApoptosis (when disruption leads to programmed cell death)Necrosis (when disruption causes uncontrolled cell death)
04

Disease associations

Cancer(Potentially other conditions if context involves immune or infectious mechanisms, but primarily cancer)
05

Safety considerations

Off-target toxicity to non-tumor (normal) cells if specificity is inadequateInduction of acute inflammation or cell lysis in healthy tissuesPotential for immune-related adverse effects if immune cells are involved in membrane-disruptive strategies
06

Interacting drugs

Many anticancer peptides (AMPs/ACPs), liprotides, various membranolytic agents
07

Biomarkers

Loss of membrane potentialIncreased uptake of membrane-impermeable dyes (e.g., PI staining in cytotoxicity assays)Release of cytosolic components (such as LDH)

Beyond the preview

Go deeper on Tumor cell membrane disruption.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Tumor cell membrane disruption.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call